Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2025-12-25 @ 9:10 PM
Study NCT ID:
NCT02453256
Status:
COMPLETED
Last Update Posted:
2020-03-09
First Post:
2015-05-21
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-11-20
Start Date Type:
ACTUAL
Primary Completion Date:
2018-01-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-02-04
Completion Date Type:
ACTUAL
First Submit Date:
2015-05-21
First Submit QC Date:
None
Study First Post Date:
2015-05-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-02-06
Results First Submit QC Date:
None
Results First Post Date:
2019-04-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-03-05
Last Update Post Date:
2020-03-09
Last Update Post Date Type:
ACTUAL